A phase II study of tumor ablation in patients with metastatic sarcoma stable on chemotherapy
The Oncologist Mar 08, 2018
Hirbe AC, et al. - Based on this prospective study it was suggested for the first time that ablation therapy for metastatic sarcoma can provide a significant progression-free interval off therapy in selected patients who are stable on chemotherapy.
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
